| Canadian
Collaborative Project on Genetic Susceptibility to MS, Phase 2:
Rationale and Method
A.D.
Sadovnick, N.J. Risch, G.C. Ebers and the Canadian Collaborative
Study Group *
Abstract:
Background: Results from the Canadian Collaborative
Project on Genetic Susceptibility to Multiple Sclerosis (MS)-Phase
1 (CCPGSMS-Phase 1) together with other family data published
since 1982 have led to the following conclusions about the etiology
of MS: (i) genetic and non-genetic (environmental) factors are
involved in the etiology of MS on a population basis; (ii) the
familial aggregation of MS is genetic; (iii) maternal factors
do not influence the risk for siblings to develop MS; and (iv)
MS appears to be oligogenic. The present paper describes the
rationale and methodology for the CCPGSMS-Phase 2. Method: The
CCPGSMS-Phase 2 is a nation-wide collaborative effort involving
all the 15 Canadian MS clinics. A series of structured questionnaires
is administered to MS index cases, spouse controls and mothers
of index cases and spouse controls (if available) by trained
interviewers. Blood samples are taken for molecular genetic
studies. This national effort is coordinated by the MS Clinics
in Vancouver and London. Results: The CCPGSMS-Phase
2 is in progress so specific results are not available. The
study is designed to (i) increase the database for genetic epidemiological/molecular
genetic research and (ii) gather population-based data to further
our understanding of the non-genetic factors in the etiology
of MS. Conclusions: It is anticipated that the
results from this study will impact on the eventual prevention,
cure and treatment of MS.
|
Can.
J. Neurol. Sci. 1998; 25: 216-221
|
|